Profile for European Patent Office Patent: 3023506
✉ Email this page to a colleague
US Patent Family Members and Approved Drugs for European Patent Office Patent: 3023506
| US Patent Number | US Expiration Date | US Applicant | US Tradename | Generic Name |
|---|---|---|---|---|
| ⤷ Start Trial | Jul 24, 2030 | Vanda Pharms Inc | BYSANTI | milsaperidone |
| ⤷ Start Trial | Oct 28, 2030 | Vanda Pharms Inc | BYSANTI | milsaperidone |
| ⤷ Start Trial | Oct 28, 2030 | Vanda Pharms Inc | FANAPT | iloperidone |
| ⤷ Start Trial | Apr 5, 2030 | Vanda Pharms Inc | BYSANTI | milsaperidone |
| ⤷ Start Trial | Apr 5, 2030 | Vanda Pharms Inc | FANAPT | iloperidone |
| >US Patent Number | >US Expiration Date | >US Applicant | >US Tradename | >Generic Name |
